ArticleBioengineered2021

Silencing Aurora-kinase-A (AURKA) reinforced the sensitivity of diffuse large B-cell lymphoma cells to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) via suppressing β-Catenin and RAS-extracellular signal-regulated protein kinase (ERK1/2) pathway.

Shaoxiong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.